source
- AstraZeneca says it remains confident in its ADC pipeline after dropping two underperforming candidatesAstraZeneca executives told Fierce they are very confident in their internally developed antibody‑drug conjugate (ADC) program despite recent setbacks. The company has discontinued two ADC candida…
- Labcorp unveils direct-to-consumer genetic health panel covering 163 genes and 100+ conditionsLabcorp announced the launch of a new direct-to-consumer test called the Marker by Labcorp Genetic Health Panel. The panel examines 163 genes to assess risk for more than 100 hereditary conditions…